Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 21, 2013
Results Revealed at CIT 2013
-
Mar 13, 2013
Deadly but preventable cancer is a focus during colorectal cancer awareness month
-
Mar 10, 2013
Separate study demonstrates PROMUS Element stent has significantly less vessel straightening than the Xience V® stent.
-
Mar 9, 2013
WATCHMAN® device continues to demonstrate positive clinical outcomes for patients with atrial fibrillation.
-
Mar 9, 2013
Preliminary data in PREVAIL clinical trial met two out of three co-primary endpoints.
-
Mar 6, 2013
First presentation of the preliminary results of all three co-primary endpoints to be revealed during American College of Cardiology 2013 Annual Scientific Sessions.
-
Mar 6, 2013
New tool available to assist in the treatment of peripheral arterial disease.
-
Mar 4, 2013
Clinical presentations will provide new insights on Boston Scientific research in cardiovascular disease, including aortic valve disease and atrial fibrillation.
-
Feb 21, 2013
Boston Scientific will participate in the healthcare conference on February 26 in New York. Learn how to watch the webcast or replay.
-
Feb 20, 2013
Extensive sales resources, distribution network and service capabilities are expected to enable Boston Scientific to reach substantially more accounts, customers and patients in Japan.